A fairer world requires fairer tech. Here’s why.
In the decade ahead, a wave of technological solutions will touch and transform every part of our lives. These new solutions could either tackle existing problems — or exacerbate them while creating others. As tech can scale both progress or harm, the time is ...
Biotech future of promise and peril looms larger and closer
Emerging technology poses new and novel questions. Unfortunately, the time to answer them is growing short.
Kyoto University project aims to supply iPS cells widely at low cost
The aim of the project is to supply the cells to 1,000 patients per year at ¥1 million per person.
Japan team uses stem cells to spawn 1,700 trout from single fish
The researchers hope to apply the technique to bluefin tuna within around five years.
Japan's AnGes speeds toward 2021 rollout in coronavirus 'vaccine war'
The Osaka-based firm got a headstart in the vaccine development by repurposing its hypertension vaccine, which had already passed various safety hurdles.
Japan researchers create tiny bronchi to develop drug for COVID-19
It is hoped the miniature organ will serve as a better model for evaluating anti-viral drugs' efficacy than a single cell.
Japanese researchers to test blood thinner for coronavirus treatment
A blood thinner used to treat pancreatitis and kidney disease has been identified as a potential therapy for COVID-19 patients, with clinical trials in Japan possibly set to begin within a month, researchers at the University of Tokyo said Wednesday. The drug, known by the ...
Lab-grown meat? Dutch start-up keeps pork on your plate without wrecking the planet
A Dutch start-up may have found a workaround for eco-conscious consumers struggling to give up meat: pork grown in a laboratory that doesn't harm animals or damage the planet. Meatable will this summer unveil its first pork prototype made entirely from cultured animal cells instead ...
Osaka University transplants iPS cell-based heart cells in world's first clinical trial
An Osaka University team said it has carried out the world's first transplant of cardiac muscle cells created from iPS cells in a physician-initiated clinical trial. In the clinical project to verify the safety and efficacy of the therapy using induced pluripotent stem cells, Yoshiki ...
An expert panel of the health ministry on Friday approved a clinical research program proposed by a Kyoto University team to transplant cartilage made from induced pluripotent stem (iPS) cells to damaged knee joints. Professor Noriyuki Tsumaki and other members of the team are planning ...
Defying local skepticism and 'Tokyo first' mentality, Science Park thrives in rural Yamagata
When Keio University professor Masaru Tomita accepted an offer in 2000 to head a new science lab in the city of Tsuruoka, Yamagata Prefecture, his fellow researchers — shocked at what they evidently considered his relegation to the countryside — warned him that his ...
Rich and poor debate treaty on plant gene data as climate change hits crops
Ahead of renewed negotiations to revise a global treaty in Rome on Monday, rich and poor countries are at loggerheads over how to share genetic plant data that could help breed crops better able to withstand climate change. The little-known agreement is seen as crucial ...
